Mark Chalos in The Tennessean on United Airlines as the Iceberg’s Tip of Bad Corporate Behavior

Mark Chalos in The Tennessean on United Airlines as the Iceberg's Tip of Bad Corporate Behavior

Lieff Cabraser Nashville office Managing Partner Mark Chalos is no fan of unleashed corporations. As an opinion piece in The Tennessean makes clear, Chalos sees incidents like United Airlines’ recent behavior with respect to a physician manhandled off a flight to make room for an airline employee as emblematic of a system where critical regulation has been steadily eroded, of years of corporate efforts to “eliminate the mechanisms that hold them accountable for their bad behavior.” [Read more…]

Judges Opting for Rapid Self-Education in Complex Cases

Judges Opting for Rapid Self-Education in Complex Cases

The Recorder reveals that in a wide variety of complex cases, judges are rising to the challenges posed by arcane and multiplex underlying factual issues by seeking to rapidly educate themselves about the nuances of various detailed and complex matters. These topics often include matters of science and technology as well as patent and invention strategies. In some instances, judges have taken the unusual step of asking scientists and inventors to make presentations at tech tutorials in an effort to bypass advocacy in pursuit of more straightforward info. [Read more…]

American Progressives Band Together For Resistance In The Trump Era

American Progressives Band Together For Resistance In The Trump Era

As many as five million people nationwide attended the Women’s March on January 21. The following week, 175,000 individuals showed up at airports and public squares protesting the Muslim travel ban, with 50,000 more standing forth in other similar protests by early March. Around 150,000 people are regularly attending their congressional representatives’ town halls or appearing at “Resist Trump” Tuesday events. [Read more…]

Female Lawyers Continue to Struggle with Shattering the Glass Ceiling

Female Lawyers Continue to Struggle with Shattering the Glass Ceiling

Over the past five years, only 16.5% of lead attorney spots have gone to female lawyers in the still largely male-dominated realm of multidistrict litigation (MDLs). In spite of the progress women have made in the law generally, and some growth in MDL leadership positions, female lawyers are still outnumbered 3 to 1 in MDLs by their male counterparts, reports Law360. [Read more…]

Kenneth Byrd in Nashville Scene on Big Tobacco Sponsorship of Schools

Kenneth Byrd Quoted in Nashville Scene on Tobacco Sponsorship of Schools

The Nashville Scene reports that cigarette giant Phillip Morris, now known as Altria, will be the founding sponsor of the 7th Annual Academies of Nashville gala, an event put on by the Nashville Chamber of Commerce honoring teachers and principals, and recognizing partnerships between business and schools. [Read more…]

New Bill Focuses on Class Actions: What Does This Mean For Defense and Plaintiffs’ Attorneys?

New Bill Focuses on Class Actions: What Does This Mean For Defense and Plaintiffs’ Attorneys?

A new bill focusing on class actions was approved by the House Judiciary Committee on February 15th on a 19 to 12 vote. Known as the 2017 Fairness in Class Action Litigation Act (H.R. 985), the legislation was introduced February 9 by committee chairman Bob Goodlatte (R-Va.). [Read more…]

Dean Harvey Comments on Valeant-Kadmon Pharma Antitrust Challenges

Dean Harvey Comments on Valeant-Kadmon Pharma Antitrust Challenges

Reuters has published a compelling analysis of ongoing challenges facing pharmaceutical “rogue” Valeant with a focus on its price-inflated drug Syprine and its relationship with also-beleagured pharma company Kadmon. Among other issues, Valeant has been singled out as a prime offender in the realm of hyper-inflated pharmaceutical drugs, with, Syprine, its life-saving Wilson’s disease liver ailment treatment costing some patients nearly $300,000 for a year’s use (in 2011, Valeant priced the drug at less than $1,000 for 100 capsules, a rate that rose by 2015 to over $21,000 for the same dose). [Read more…]

How Lawyers Can Be Good Allies: A Strategic Engagement Conference

Kelly Dermody, Lieff Cabraser partner

[Guest Post to the California Civil Rights Coalition website by Kelly Dermody, Managing Partner of Lieff Cabraser’s San Francisco office and chair of the firm’s Employment practice group]

“Around 4:00 a.m. on November 9, I knew something fundamentally had changed. Our civic institutions, impartial judiciary, fair elections, and rule of law had been openly mocked and undermined. [Read more…]

Spokeo Still Standing: No Sign Of A Circuit Split

Spokeo Still Standing: No Sign Of A Circuit Split

In an expert analysis article published by Law360 (subscription) entitled “Spokeo Still Standing: No Sign Of A Circuit Split,” Lieff Cabraser attorneys Nicholas Diamand and Andrew Kaufman review the U.S. Supreme Court’s May decision in Spokeo Inc. v. Robins, et al. The decision “reaffirmed that, under principles of federal jurisdiction, invasions of privacy give plaintiffs standing to assert their rights in federal court,” wrote Diamand and Kaufman. [Read more…]

Why Drug Prices Skyrocket Despite Market Competition

Pharmacy

The LA Times has published an excellent piece on the skyrocketing costs of U.S. prescription drugs despite marketplace competition. The absence of competition for a good or service traditionally provides fertile ground for cost escalation and price-gouging, classic greedy anticompetitive behavior, but the Times’ article explores the prevalence of continuing drug cost escalations in the U.S. even where competition does exist. [Read more…]